These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 24107810)
1. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines. Ilias I; Meristoudis G Clin Nucl Med; 2013 Oct; 38(10):810. PubMed ID: 24107810 [No Abstract] [Full Text] [Related]
2. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines. Derlin T; Busch JD; Wisotzki C; Schoennagel BP; Bannas P; Papp L; Klutmann S; Habermann CR Clin Nucl Med; 2013 Jan; 38(1):e1-6. PubMed ID: 22996238 [TBL] [Abstract][Full Text] [Related]
3. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618 [TBL] [Abstract][Full Text] [Related]
4. The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma. Meyer-Rochow GY; Schembri GP; Benn DE; Sywak MS; Delbridge LW; Robinson BG; Roach PJ; Sidhu SB Ann Surg Oncol; 2010 Feb; 17(2):392-400. PubMed ID: 19949879 [TBL] [Abstract][Full Text] [Related]
5. [Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy]. Noblet-Dick M; Grunenberger F; Brunot B; Jaeck D; Schlienger JL Rev Med Interne; 2003 Jun; 24(6):358-65. PubMed ID: 12814824 [TBL] [Abstract][Full Text] [Related]
6. [123I-MIBG SPECT-CT combined with gamma probe for radioguided localization of pheochromocytoma]. Fuertes Manuel J; Mena González E; Camacho Martí V; Hernández Fructuoso MA; Flotats Giralt A; Estorch Cabrera M; Carrió Gasset I Rev Esp Med Nucl; 2005; 24(6):418-21. PubMed ID: 16324520 [TBL] [Abstract][Full Text] [Related]
7. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma. Fukuoka M; Taki J; Mochizuki T; Kinuya S Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198 [TBL] [Abstract][Full Text] [Related]
8. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma. Sharma P; Dhull VS; Jeph S; Reddy RM; Singh H; Naswa N; Bal C; Kumar R Clin Nucl Med; 2013 Sep; 38(9):e346-53. PubMed ID: 23510889 [TBL] [Abstract][Full Text] [Related]
9. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging. Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024 [TBL] [Abstract][Full Text] [Related]
13. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459 [TBL] [Abstract][Full Text] [Related]
15. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters]. Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441 [TBL] [Abstract][Full Text] [Related]
16. A case of added value of Paques F; Hamoir E; Lovinfosse P; Hustinx R; Withofs N Acta Chir Belg; 2017 Jun; 117(3):192-195. PubMed ID: 27735216 [TBL] [Abstract][Full Text] [Related]
17. Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images. Kizu H; Takayama T; Tsushima H; Noguchi A; Nakajima K; Onoguchi M; Kinuya S J Nucl Med Technol; 2008 Dec; 36(4):186-8. PubMed ID: 19008288 [TBL] [Abstract][Full Text] [Related]
18. Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. Nakajo M; Shapiro B; Glowniak J; Sisson JC; Beierwaltes WH J Nucl Med; 1983 Dec; 24(12):1127-34. PubMed ID: 6644373 [TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging. Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196 [TBL] [Abstract][Full Text] [Related]
20. Comparison of 68 Ga-DOTATATE PET/CT and 123 I-MIBG SPECT/CT in the Imaging of Functional Pheochromocytoma in an Adolescent Patient With Von Hippel-Lindau Syndrome. Singh K; Sandler G; Hahn D; Chung DK Clin Nucl Med; 2024 Sep; 49(9):e451-e452. PubMed ID: 38861407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]